{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:59:13Z","timestamp":1780991953441,"version":"3.54.1"},"reference-count":61,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s594882","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:25:10Z","timestamp":1780989910000},"page":"1-13","source":"Crossref","is-referenced-by-count":0,"title":["US Retina Specialists\u2019 Preferences for Geographic Atrophy Treatment"],"prefix":"10.2147","volume":"Volume 20","author":[{"given":"Karl","family":"Csaky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Pepio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2314-714X","authenticated-orcid":true,"given":"Caitlin","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9069-8446","authenticated-orcid":true,"given":"Bennett","family":"Levitan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyet","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Irony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Krucien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Doldos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5886-1933","authenticated-orcid":true,"given":"Jennifer","family":"Whitty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.18553\/jmcp.2023.29.5-a.s2","volume":"29","author":"Bakri","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.ophtha.2017.11.036","volume":"125","author":"Chakravarthy","year":"2018","journal-title":"Ophthalmology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/aos.15794","volume":"101","author":"Krogh Nielsen","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s40123-023-00667-3","volume":"12","author":"Morga","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.22599\/bioj.137","volume":"15","author":"Carlton","year":"2019","journal-title":"Br Ir Orthopt J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1097\/iae.0000000000001392","volume":"37","author":"Boyer","year":"2017","journal-title":"Retina"},{"key":"ref9","unstructured":"US Food and Drug Administration. SYFOVRE\u2122 (pegcetacoplan injection). Highlights of prescribing information. 2021. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/217171s002lbl.pdf. Accessed May 29, 2026."},{"key":"ref10","unstructured":"US Food and Drug Administration.IZERVAY\u2122 (avacincaptad pegol intravitreal solution). Highlights of prescribing information. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/217225s000lbl.pdf. Accessed 10, Nov, 2024."},{"key":"ref11","unstructured":"TGA. SYFOVRE\u2122 (Apellis Australia Pty Ltd). 2025. Available from: https:\/\/www.tga.gov.au\/resources\/prescription-medicines-registrations\/syfovre-apellis-australia-pty-ltdhttps:\/\/pi.apellis.com\/files\/PI_SYFOVRE.pdf. Accessed May 29, 2026."},{"key":"ref12","unstructured":"US Food and Drug Administration. SYFOVRE\u2122 (pegcetacoplan injection), for intravitreal use. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/217171s002lbl.pdf. Accessed 10, Nov, 2024."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/s0140-6736(23)01520-9","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"key":"ref15","unstructured":"Iveric Bio receives U.S. FDA approval for IZERVAY\u2122 (avacincaptad pegol intravitreal solution), a new treatment for geographic atrophy. 2023. Available from: https:\/\/www.prnewswire.com\/news-releases\/iveric-bio-receives-us-fda-approval-for-izervay-avacincaptad-pegol-intravitreal-solution-a-new-treatment-for-geographic-atrophy-301894042.html. Accessed 10, Nov, 2024."},{"key":"ref16","unstructured":"Becker Z. Experts flag eye inflammation reports tied to Apellis\u2019 geographic atrophy med Syfovre. 2024. Available from: https:\/\/www.fiercepharma.com\/pharma\/experts-flag-eye-inflammation-reports-tied-apellis-geographic-atrophy-med-syfovre. Accessed 14, Nov, 2024."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/24741264231220224","volume":"8","author":"Witkin","year":"2024","journal-title":"J Vitreoretin Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2024.06.013","author":"Heier","year":"2024","journal-title":"Ophthalmology"},{"key":"ref19","unstructured":"ClinicalTrials.gov. A study to evaluate intravitreal JNJ-81201887 (AAVCAGsCD59) compared to sham procedure for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). 2024. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05811351. Accessed 10, Dec, 2024."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/aos.15801","volume":"101","author":"Trivizki","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2147\/opth.S364200","volume":"16","author":"Ghoraba","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.drudis.2019.05.001","volume":"24","author":"Soekhai","year":"2019","journal-title":"Drug Discov Today"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1002\/hec.4599","volume":"31","author":"Huls","year":"2022","journal-title":"Health Econ"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"Bridges","year":"2011","journal-title":"Value Health"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40273-018-0734-2","volume":"37","author":"Soekhai","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1097\/OPX.0000000000000320","volume":"91","author":"McCloud","year":"2014","journal-title":"Optom Vis Sci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s40271-016-0179-7","volume":"9","author":"Danner","year":"2016","journal-title":"Patient"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e0261955","DOI":"10.1371\/journal.pone.0261955","volume":"16","author":"Gallego-Pinazo","year":"2021","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00417-013-2412-6","volume":"252","author":"Droege","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.2147\/OPTH.S273564","volume":"14","author":"Bhagat","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"18996","DOI":"10.1038\/s41598-021-98568-7","volume":"11","author":"Jacobs","year":"2021","journal-title":"Sci Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1001\/jamaophthalmol.2021.1874","volume":"139","author":"Fenwick","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1167\/iovs.07-0559","volume":"49","author":"Aspinall","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"6864","DOI":"10.1167\/iovs.15-16705","volume":"56","author":"Yu","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41433-019-0676-8","volume":"34","author":"Li","year":"2020","journal-title":"Eye"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ogla.2019.08.007","volume":"2","author":"Le","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/bjophthalmol-2019-313899","volume":"104","author":"Fenwick","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1167\/iovs.05-1244","volume":"47","author":"Bhargava","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jval.2017.04.022","volume":"20","author":"Danner","year":"2017","journal-title":"Value Health"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/eye.2016.18","volume":"30","author":"Baxter","year":"2016","journal-title":"Eye"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2147\/PPA.S228890","volume":"14","author":"Joko","year":"2020","journal-title":"Patient Prefer Adherence"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"993","DOI":"10.2147\/PPA.S101584","volume":"10","author":"Vennedey","year":"2016","journal-title":"Patient Prefer Adherence"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1136\/bjo.2008.140483","volume":"92","author":"Bhargava","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.ophtha.2015.12.001","volume":"123","author":"Mueller","year":"2016","journal-title":"Ophthalmology"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","volume":"16","author":"Reed Johnson","year":"2013","journal-title":"Value Health"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"5612","DOI":"10.1002\/sim.9583","volume":"41","author":"Postmus","year":"2022","journal-title":"Stat Med"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1177\/0272989x19873630","volume":"39","author":"Tervonen","year":"2019","journal-title":"Med Decis Making"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/j.1542-4774.2011.01015.x","volume":"9","author":"Dohmen","year":"2011","journal-title":"J Eur Economic Assoc"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1017\/S1930297500003260","volume":"7","author":"Szrek","year":"2012","journal-title":"Judgm Decis Mak"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1023\/A:1022558715350","volume":"30","author":"Hensher","year":"2003","journal-title":"Transportation"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"100170","DOI":"10.1016\/j.jocm.2019.100170","volume":"32","author":"Hess","year":"2019","journal-title":"J Choice Model"},{"key":"ref52","volume-title":"Getting Started with Conjoint Analysis: Strategies for Product Design and Pricing Research","year":"2019"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/0272989x221132266","volume":"43","author":"Fairchild","year":"2023","journal-title":"Med Decis Making"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/1099-1255(200009\/10)15:5<447::AID-JAE570>3.0.CO;2-1","volume":"15","author":"McFadden","year":"2000","journal-title":"J Appl Econom"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10198-018-0954-6","volume":"19","author":"Quaife","year":"2018","journal-title":"Eur J Health Econ"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ajo.2024.02.021","volume":"263","author":"Csaky","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"ref57","unstructured":"European Medicines Agency. Qualification Opinion of IMI PREFER; 2022."},{"key":"ref58","unstructured":"European Medicines Agency. ICHE22Guideline on General Considerations for Patient Preference Studies; 2025."},{"key":"ref59","unstructured":"US Food and Drug Administration. Incorporating Voluntary Patient Preference Information Over the Total Product Life Cycle. Guidance for Industry, Food and Drug Administration Staff, and Other Interested Parties; 2026."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1186\/s12885-023-11598-4","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Cancer"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"The Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS): design implications, Control Clin Trials. 1999;20(6):573\u2013600. AREDS report no. 1. doi:10.1016\/s0197-2456(99)00031-8","DOI":"10.1016\/S0197-2456(99)00031-8"}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/116162","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/116162","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:25:32Z","timestamp":1780989932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/us-retina-specialists-preferences-for-geographic-atrophy-treatment-peer-reviewed-fulltext-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":61,"URL":"https:\/\/doi.org\/10.2147\/opth.s594882","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}